| 注册
首页|期刊导航|河北医学|舒芬太尼联合丙泊酚用于无痛人流的临床观察

舒芬太尼联合丙泊酚用于无痛人流的临床观察

陈颂英

河北医学2012,Vol.18Issue(7):916-919,4.
河北医学2012,Vol.18Issue(7):916-919,4.DOI:10.3969/j.issn.1006-6233.2012.07.017

舒芬太尼联合丙泊酚用于无痛人流的临床观察

Clinical Observation of Sufentanil Combined with Propofol for Painless Artificial Abortion

陈颂英1

作者信息

  • 1. 广东省平远县妇幼保健院,广东,平远,514600
  • 折叠

摘要

Abstract

Objective: To investigate the sufentanil combined with propofol for painless clinical effects. Method: In our hospital from Sep. 2009 to Feb. 2011 for obstetrics and gynecology clinic diagnosed with artificial abortion and were willing to end pregnancy, pregnant women, 90 cases of pregnant women were ran-domly divided into three groups, namely propofol combined with sufentanil group ( A ), propofol and fentanyl in combination group ( B group ), propofol plus saline group ( C group ), three groups of 30 patients were analyzed and compared three groups of clinical indicators . Result: Three groups 2min after administration compared with the preoperative central venous pressure and heart rate low, the difference was statistically significant ( P <0. 05 ); A group of patients was significantly lower than the B group, C group, three groups were statistically difference ( P <0. 05 ); A, B group the incidence of postoperative pain are lower than the C group, and postoperative pain in group A than in group B the incidence of low, were statistically significant ( P <0. 05 ). Conclusion: Propofol and sufentanil anesthesia for painless compatibility is good effect, rapid onset, safe and stable, with less adverse reactions, suitable for the promotion of abortion.

关键词

舒芬太尼/丙泊酚/无痛人流

Key words

Sufentanil/Propofoll/Painless artificial abortion

引用本文复制引用

陈颂英..舒芬太尼联合丙泊酚用于无痛人流的临床观察[J].河北医学,2012,18(7):916-919,4.

河北医学

OACSTPCD

1006-6233

访问量0
|
下载量0
段落导航相关论文